Compare Segar Kumala Indonesia Tbk (BUAH) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Segar Kumala Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Segar Kumala Indonesia Tbk trades at Rp510 (market cap 1.02T, 50.4K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume). The key difference: Segar Kumala Indonesia Tbk is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Segar Kumala Indonesia Tbk is more actively traded (50.4K versus 7.6K). Which is the better fit depends on your goals.
| BUAH | DGNS | |
|---|---|---|
Market Cap | 1.02T | 319B |
Volume | 50.4K | 7.6K |
Lot | 504 | 76 |
Turnover | 25.66M | 1.74M |
Average Price | 509.08 | 229.21 |
Value | 25.66M | 1.74M |
Indicative Equilibrium Price | 510 | 232 |
Indicative Equilibrium Volume | 400 | 200 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Segar Kumala Indonesia Tbk
PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
